Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2005-08-23
2005-08-23
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S030000, C435S032000, C435S261000
Reexamination Certificate
active
06933129
ABSTRACT:
An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested, cultured and separately exposed to a plurality of treatments and/or therapeutic agents for the purpose of objectively identifying. One particularly important tissue sample preparation technique is the initial preparation of cohesive multicellular particulates of the tissue sample. For assays concerning cancer treatment, a two-stage evaluation is contemplated in which both acute cytotoxic and longer term inhibitory effect of a given anti-cancer agent are investigated. The tissue sample technique of the present invention is also useful in assaying expression and/or secretion of various markers, factors or antigens present on or produced by the cultured cells for diagnostic purposes and for using such expression to monitor the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents.
REFERENCES:
patent: 4423145 (1983-12-01), Stampfer et al.
patent: 4559299 (1985-12-01), Rotman
patent: 4668618 (1987-05-01), Thornthwaite
patent: 4816395 (1989-03-01), Hancock et al.
patent: 4937187 (1990-06-01), Rotman
patent: 4996145 (1991-02-01), Weisenthal
patent: 5242806 (1993-09-01), Yen-Maguire et al.
patent: 5270172 (1993-12-01), Morgan
patent: 5403574 (1995-04-01), Piwnica-Worms
patent: 5443950 (1995-08-01), Naughton et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5705270 (1998-01-01), Soon-Shiong et al.
patent: 5728541 (1998-03-01), Kornblith
patent: 5789158 (1998-08-01), Knowles et al.
patent: 5874218 (1999-02-01), Drolet et al.
patent: 5888765 (1999-03-01), Patterson et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5972639 (1999-10-01), Parandoosh
patent: 6008007 (1999-12-01), Fruehauf et al.
patent: 6020473 (2000-02-01), Keyt et al.
patent: 6111092 (2000-08-01), Williamson
patent: 6261795 (2001-07-01), Fruehauf et al.
patent: 6303324 (2001-10-01), Fruehauf
patent: 6335170 (2002-01-01), Orntoft
patent: 6416967 (2002-07-01), Kornblith
patent: 6511806 (2003-01-01), Fruehauf et al.
patent: 6664062 (2003-12-01), Stanton
patent: 2002/0168679 (2002-11-01), Naus et al.
patent: 2002/0192638 (2002-12-01), Kornblith
patent: 2003/0096290 (2003-05-01), Fruehauf et al.
patent: 2004/0023375 (2004-02-01), Kornblith et al.
patent: 2004/0072722 (2004-04-01), Kornblith et al.
patent: 2004/0086888 (2004-05-01), Kornblith et al.
patent: WO96/10742 (1996-04-01), None
patent: WO 96/10742 (1996-04-01), None
patent: WO98/02038 (1998-01-01), None
patent: WO02/33117 (2002-04-01), None
patent: WO2004/015065 (2004-02-01), None
patent: WO2004/035833 (2004-04-01), None
Gerweck, L. Radiation Sensitivity of Cultured Human Glioblastoma Cells. Radiology 125(1)231-234, Oct. 1977.
Kornblith P. Variations in Response of Human Brain Tumors to BCNU in vitro. J Neurosurg 48:580-586, 1978.
Kornblith P. Role of Tissue Culture in Prediction of Malignancy. Clinical Neurosurgery vol. 25, pp. 347-376, 1978.
Dudley D. A Human Endometrial Explant System. Am J Obstet Gynecol 167(6)1774-1780, 1992.
Broadley C. A Tissue Culture Model for the Study of Canine Vocal Fold Fibroblasts. Laryngoscope 105(1)23-27, Jan. 1995.
Hoffman R. The Three-Dimensional Question: Can Clinically Relevant Tumor Drug Resistance Be Measured In Vitro? Cancer and Metastasis Reviews 13(2)169-173, Feb. 1994.
Dietel M. In Vitro Prediction of Cytostatic Drug Resistance in Primary Cell Cultures of Solid Malignant Tumours. Eur J Cancer 29A(3)416-420, 1993.
Fulda, S. Antiproliferative Potential of Cytostatic Drugs on Neuroblastoma Cells in Vitro. Eur J of Cancer 31 A(4)616-621, 1995.
Kaaijk P. Daunorubicin and Doxorubicin but Not BCNU Have Deleterious Effects on Organtypic Multicellular Spheroids of Gliomas. British J of Cancer 74(2)187-193, Jul. 1996.
Alley M. Morphometric and Colorimetric Analyses of Human Tumor Cell Line Growth and Drug Sensitivity in Soft Agar Culture. Cancer Research 51:1247-1256, Feb. 1991.
Andreotti P. TCA-100 tumour Chemosensitivity Assay. J Biolumin Chemilumin. vol. 9:373-378, 1994.
Bosanquet, A.G., “Short-term in vitro drug sensitivity tests for cancer chemotherapy. A summary of correlations of test result with both patient response and survival,”Forum4(2):179-195 (1994).
Fruehauf, J.P., “In vitro assay-assisted treatment selection for women with breast or ovarian cancer,”Endocrine-Related Cancer9:171-182 (2002).
McGuire et al., “In vitro assays to predict drug sensitivity and drug resistance:A panel discussion,” Breast Cancer Research and Treatment12:7-21 (1988).
Robert, J., “Chemosensitivity testing: Prediction of response to anticancer drugs using in vitro assays,”Electronic Journal of Oncology2:198-205 (1999).
Kornblith, P., “Role of Tissue Culture in Prediction of Malignancy,”Clinical Neurosurgery, vol. 25, pp. 346-376 (1978).
Freshney, R.I.,Culture of Animal Cells: A Manual of Basic Technique, 2nd edition, pp. 107, 124-126, 179, 233-234, 290 (1987).
Guo et al., “Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports,”Nucleic Acids Research22(24):5456-5465 (1994).
Pfost et al., “A SNPshot: pharmacogenetics and the future of drug therapy,”TIBTECH18:334-338 (Aug., 2000).
Raju, G.C., “The histological and immunohistochemical evidence of squamous metaplasia from the myoepithelial cells in the breast,”Histopathology17(3):272-275 (1990).
Stephens, J.C., “Single-nucleotide Polymorphisms, Haplotypes, and Their Relevance to Pharmacogenetics,”Molecular Diagnosis4(4):309-317 (1999).
Tannock et al.,The Basic Science of Oncology, 2nd edition, pp. 247-248, 261-265, 303-306(1992).
Becton-Dickinson Catalog, Anti-Cytokeratin (CAM 5.2) Reagent, pp. 1-11 (1997).
Boehringer Mannheim Catalog, Anti-Cytokeratin AE1/AE3, (1996).
DAKO Catalog, Specification Sheet for Monoclonal Mouse Anti-Human Epithelial Membrane Antigen, pp. 1-2 (1996).
Burczynski, M., et al., “Toxicogenomics-Based Discrimination of Toxic Mechanism in HepG2 Human Hepatoma Cells,” Toxicological Sciences, vol. 58, No. 2, pp. 399-415 (2000).
Cilley, R., et al., “Fetal Lung Development: Airway Pressure Enhances the Expression of Developmental Genes,” Journal of Pediatric Surgery, vol. 35, No. 1, pp. 113-119 (2000).
Frykholm, G., et al., “Heterogeneity in Antigenic Expression and Radiosensitivity in Human Colon Carcinoma Cell Lines,” In Vitro Cell Dev. Biol., vol. 27A, pp. 900-906 (1991).
Gamboa, G., et al., “Characterization and Development of UCI 107, a Primary Human Ovarian Carcinoma Cell Line,” Gynecologic Oncology, vol. 58, pp. 336-343 (1995).
Goldsworthy, T., et al., “Concepts, Labeling Procedures, and Design of Cell Proliferation Studies Relating to Carcinogenesis,” Environmental Health Perspectives, vol. 101, supp. 5, pp. 59-66 (1993).
Gress, T., “Development of a Database on Transcribed Sequences in Tumour Cells and Identification of Changes in Transcription Patterns Related to Transformation and Other Tumour Cell Properties for the Global Finger Printing Analysis of Human Pancreatic Carcinoma cDNA Libraries,” Biomed1. Health Res., vol. 24, pp. 171-181 (1998).
Kitamura, M., et al., “Chemosensitivity of Gastric Cancer Using Adhesive Tumor Cell Culture System,” Oncology Reports, vol. 2, No. 1, pp. 27-31 (1995).
Kornblith, P., et al., “Variations in Response of Human Brain Tumors to BCNU In Vitro,” Journal of Neurosurgery, vol. 48, No. 4, pp. 580-586 (1978).
Nance, K., et al., “Immunocytochemical Panel for the Identification of Malignant Cells in Serous Effusions,” Am J Clin Pathol, vol. 95, pp. 867-874 (1991).
Persons, D., et al., “Interphase Molecular Cytogenetic Analysis of Epithelial Ovarian Carcinomas,” American Journal of Pathology, vol. 142, No. 3, pp. 733-741 (1993).
Pinkus, G., et al., “Opti
Gitomer Ralph
Morgan & Lewis & Bockius, LLP
Precision Therapeutics, Inc.
LandOfFree
Method for culturing and assaying cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for culturing and assaying cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for culturing and assaying cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3481865